Brawn Biotech Gross Margin

Gross Margin of Brawn Biotech is 11.40 % in 2026.

Gross Margin of Brawn Biotech changed from 12.92 % to 11.40 %, representing a -11.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Brawn Biotech since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Brawn Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.